Filing Overview
Trinity Capital Inc. filed a Form 8-K dated June 21, 2023, reporting the results of its reconvened 2023 Annual Meeting of Stockholders. The meeting was initially called to order on June 14, 2023 and adjourned to allow additional solicitation of votes on Proposal 3.
Business Context and Reporting Period
The filing concerns corporate governance and shareholder authorization matters, not quarterly or annual financial results. As of the April 17, 2023 record date, 35,969,419 common shares were outstanding and entitled to vote.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, net asset value per share, or other operating or financial performance metrics.
Annual Meeting Results
- Proposal 1—Election of Directors: Stockholders re-elected Ronald E. Estes and Michael E. Zacharia to serve until the 2026 Annual Meeting and until their successors are elected and qualified. Estes received 16,626,476 votes for, 2,972,733 against, and 268,357 abstentions. Zacharia received 17,151,073 votes for, 2,450,212 against, and 266,281 abstentions.
- Proposal 2—Declassification of the Board: Stockholders approved amendments to the Company’s Articles of Amendment and Restatement to declassify the Board of Directors, subject to a four-year sunset. The proposal received 19,309,325 votes for, 341,338 against, and 216,903 abstentions.
- Proposal 3—Issuance of Shares Below Net Asset Value: Stockholders approved authorization for the Company to sell or otherwise issue up to 25% of its then-outstanding common shares at an offering price below then-current net asset value per share. Among all stockholders, the proposal received 15,928,177 votes for, 3,354,008 against, and 585,381 abstentions. Among stockholders without affiliates, it received 13,139,267 votes for, 3,354,008 against, and 585,381 abstentions.
Material Changes, Outlook, and Risks
The filing does not provide financial guidance, an operating outlook, management commentary on performance, or new risk disclosures. The authorization to issue shares below net asset value could result in dilution to existing stockholders and warrants attention to the terms, pricing, timing, and use of proceeds of any future issuance.
Key Facts to Verify
- Whether and when the Company uses the authorization to issue shares below net asset value.
- The pricing, number of shares, dilution impact, and use of proceeds of any future offering.
- The effective timing and precise implementation of the Board declassification amendment and its four-year sunset.
- Subsequent filings for changes in the Board, capital structure, net asset value, liquidity, and financial performance.